Key points are not available for this paper at this time.
Both treatment protocols were efficacious and well tolerated. The doxorubicin-piroxicam treatment was no more effective regarding response rate, remission duration, or survival duration, compared with the control group treated with doxorubicin alone.
Mutsaers et al. (Sat,) studied this question.